Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00305448 | A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg(FINDER I) | completed | Phase 2 | 143 | AstraZenecaINDUSTRY | 1 | Feb 15, 2012 | clinicaltrials |
| NCT00214864 | A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer | completed | Phase 2 | 18 | Cancer Research NetworkOTHER | 1 | Feb 14, 2012 | clinicaltrials |
| NCT00006108 | Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | — | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT01108315 | Comprehensive Patient Reported Outcomes (PRO) Management for Oncology Practice | completed | Phase 1 / Phase 2 | 138 | BrightOutcomeINDUSTRY | 1 | Feb 6, 2012 | clinicaltrials |
| NCT00206466 | Biologic Correlative Taxotere/AC(TAX/AC) | completed | Phase 2 | 70 | Baylor Breast Care CenterOTHER | 1 | Jan 25, 2012 | clinicaltrials |
| NCT00623233 | Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer | completed | Phase 2 | 52 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 9, 2012 | clinicaltrials |
| NCT00532857 | Phase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Trastuzumab(PGH) | completed | Phase 2 | 53 | Jungsil RoOTHER_GOV | 1 | Jan 4, 2012 | clinicaltrials |
| NCT01070706 | Phase Ib/II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Sunitinib(PGS) | completed | Phase 1 / Phase 2 | 15 | Jungsil RoOTHER_GOV | 1 | Jan 4, 2012 | clinicaltrials |
| NCT00760370 | Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer | completed | Phase 2 | 60 | Vejle HospitalOTHER | 1 | Dec 7, 2011 | clinicaltrials |
| NCT00003887 | Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Nov 30, 2011 | clinicaltrials |
| NCT00206505 | Neoadjuvant Taxotere | completed | Phase 2 | 40 | Baylor Breast Care CenterOTHER | 1 | Nov 17, 2011 | clinicaltrials |
| NCT00196820 | Mono Efficacy of Capecitabine (MoniCa) | completed | Phase 2 | 200 | GBG Forschungs GmbHOTHER | 1 | Oct 6, 2011 | clinicaltrials |
| NCT01439191 | Study of Cipterbin®, Used Alone or With Vinorelbine in Patients With HER2/Neu-overexpressed Metastatic Breast Cancer | completed | Phase 2 | 109 | Shanghai CP Guojian Pharmaceutical Co., Ltd.INDUSTRY | 1 | Sep 23, 2011 | clinicaltrials |
| NCT01423695 | Weekly Paclitaxel and Trastuzumab in Metastatic Breast Cancer | completed | Phase 2 | 121 | WiSP Wissenschaftlicher Service Pharma GmbHOTHER | 1 | Aug 26, 2011 | clinicaltrials |
| NCT01422551 | Facilitating Positive Adaptation to Breast Cancer | completed | Phase 2 | 240 | University of MiamiOTHER | 1 | Aug 24, 2011 | clinicaltrials |
| NCT00795899 | Taxol Epirubicin Cyclophosphamide Herceptin Neoadjuvant (TECHNO) | completed | Phase 2 | 230 | GBG Forschungs GmbHOTHER | 1 | Aug 16, 2011 | clinicaltrials |
| NCT00602108 | Radiation Therapy in Treating Women Undergoing Lumpectomy for Stage I or Stage IIA Breast Cancer | completed | Phase 2 | 50 | Mayo ClinicOTHER | 0 | Aug 10, 2011 | clinicaltrials |
| NCT00515762 | Prevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling | completed | Phase 2 | 150 | Hospital San Carlos, MadridOTHER | 1 | Aug 9, 2011 | clinicaltrials |
| NCT00028639 | PS-341 in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jul 29, 2011 | clinicaltrials |
| NCT00429247 | Randomized Trial With Trastuzumab Versus Observation in Breast Cancer Patients | completed | Phase 2 | 75 | University Hospital of CreteOTHER | 1 | Jul 21, 2011 | clinicaltrials |
| NCT00629148 | Sequential Versus Simultaneous Use of Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer (MBC) | completed | Phase 2 | 60 | Fudan UniversityOTHER | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00601159 | Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC | completed | Phase 2 | 70 | Fudan UniversityOTHER | 1 | Jul 4, 2011 | clinicaltrials |
| NCT01206881 | Neoadjuvant Pegylated Liposomal Doxorubicin and Cyclophosphamide +/- Trastuzumab Followed by Docetaxel in Breast Cancer | completed | Phase 2 | 45 | Herlev HospitalOTHER | 1 | Jul 4, 2011 | clinicaltrials |
| NCT00524810 | Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer | completed | Phase 2 | 67 | ARCAGY/ GINECO GROUPOTHER | 1 | Jun 30, 2011 | clinicaltrials |
| NCT00532272 | Goserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBC | completed | Phase 2 | 78 | National Cancer Center, KoreaOTHER_GOV | 1 | Jun 27, 2011 | clinicaltrials |
| NCT00532623 | Phase II Study of Gemcitabine/Vinorelbine vs Sequential Gemcitabine Followed by Vinorelbine in Metastatic Breast Cancer | completed | Phase 2 | 82 | National Cancer Center, KoreaOTHER_GOV | 0 | Jun 27, 2011 | clinicaltrials |
| NCT00004085 | Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer | completed | Phase 1 / Phase 2 | 15 | Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyOTHER | 1 | Jun 22, 2011 | clinicaltrials |
| NCT00505271 | Safety and Efficacy Study Using Rexin-G for Breast Cancer | completed | Phase 1 / Phase 2 | 20 | Epeius BiotechnologiesINDUSTRY | 1 | Jun 10, 2011 | clinicaltrials |
| NCT00976365 | Evaluation of the Safety and Efficacy of THL-P in Metastatic Breast Cancer | completed | Phase 2 | 60 | Taiwan THL Co.LTd.INDUSTRY | 1 | Jun 9, 2011 | clinicaltrials |
| NCT00110084 | ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | 50 | Mayo ClinicOTHER | 1 | Jun 2, 2011 | clinicaltrials |
| NCT00031278 | Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 12 | PfizerINDUSTRY | 1 | May 30, 2011 | clinicaltrials |
| NCT00325234 | Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast Cancer | completed | Phase 2 | 135 | Eli Lilly and CompanyINDUSTRY | 5 | May 20, 2011 | clinicaltrials |
| NCT00645866 | Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer | completed | Phase 2 | 47 | Mayo ClinicOTHER | 0 | May 16, 2011 | clinicaltrials |
| NCT00771433 | G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer | completed | Phase 2 | 120 | Centre Francois BaclesseOTHER | 1 | May 13, 2011 | clinicaltrials |
| NCT00193076 | Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast Cancer | completed | Phase 2 | 96 | SCRI Development Innovations, LLCOTHER | 1 | May 3, 2011 | clinicaltrials |
| NCT00497809 | Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia | completed | Phase 2 | 189 | AviGenicsINDUSTRY | 2 | May 3, 2011 | clinicaltrials |
| NCT00371345 | Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast Cancer | completed | Phase 2 | 92 | Bristol-Myers SquibbINDUSTRY | 7 | Apr 26, 2011 | clinicaltrials |
| NCT00253539 | Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer | completed | Phase 2 | 3 | The Cleveland ClinicOTHER | 0 | Apr 13, 2011 | clinicaltrials |
| NCT00006825 | Liposomal Doxorubicin and Trastuzumab in Treating Women With Advanced Breast Cancer | completed | Phase 1 / Phase 2 | — | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00003035 | Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer | completed | Phase 2 | 40 | Georgetown UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00003125 | Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors | completed | Phase 2 | 24 | Georgetown UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00967824 | Tamoxifen Citrate Decision Aids for Women at Increased Risk of Breast Cancer | completed | Phase 1 / Phase 2 | 1,683 | University of Michigan Rogel Cancer CenterOTHER | 0 | Mar 24, 2011 | clinicaltrials |
| NCT01112189 | Use of Stem Cells in Lymphedema Post Mastectomy(SCL) | completed | Phase 1 / Phase 2 | 20 | Hospital Universitario Dr. Jose E. GonzalezOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00186524 | Do Community Cancer Support Groups Reduce Physiological Stress in Women With Primary Breast Cancer? | completed | Phase 2 | — | Stanford UniversityOTHER | 1 | Mar 15, 2011 | clinicaltrials |
| NCT00371254 | A Study of Dasatinib (BMS-354825) in Patients With Advanced 'Triple-negative' Breast Cancer | completed | Phase 2 | 55 | Bristol-Myers SquibbINDUSTRY | 4 | Mar 15, 2011 | clinicaltrials |
| NCT00003877 | Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 30 | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00270491 | Capecitabine Associated With Weekly Paclitaxel in Metastatic Breast Cancer. | completed | Phase 2 | 130 | ARCAGY/ GINECO GROUPOTHER | 1 | Feb 25, 2011 | clinicaltrials |
| NCT00263705 | Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study | completed | Phase 2 | 43 | Jules Bordet InstituteOTHER | 1 | Feb 24, 2011 | clinicaltrials |
| NCT00028964 | Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With Breast Cancer | completed | Phase 1 / Phase 2 | — | University of California, San FranciscoOTHER | 1 | Feb 23, 2011 | clinicaltrials |
| NCT00316407 | Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients | completed | Phase 1 / Phase 2 | 30 | Swedish Medical CenterOTHER | 1 | Feb 18, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Feb 15, 2012source: clinicaltrials